TotalMarketCap

Gain Therapeutics

GANXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$42.116 M

$0.97 -13.06%

Close of 6 Nov 2026

As of 6 Nov 2026, Gain Therapeutics (GANX) has a market capitalization of $42.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$20.2M

Loss-making

Shares outstanding

43,643,619

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #344Mereo BioPharma GroupMREO$45.0M
  2. #345Biomea FusionBMEA$42.6M
  3. #346Gain TherapeuticsGANX$42.1M
  4. #347Alterity TherapeuticsATHE$41.5M
  5. #348Actinium PharmaceuticalsATNM$41.2M

What if Gain Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$646,987.46

Per share 670,453× higher

Bitcoin $1.53T

$35,007.36

Per share 36,277× higher

Apple $5.02T

$114,925.91

Per share 119,094× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Gain Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.